TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
TBRA
Delisted
TBRA was delisted on the 31st of October, 2016.
45 hedge funds and large institutions have $147M invested in Tobira Therapeutics, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 11 closing their positions.
Holders
45
Holders Change
-1
Holders Change %
-2.17%
% of All Funds
1.2%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
10
Increased
17
Reduced
12
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BB
1
BB Biotech
Schaffhausen,
Switzerland
|
$5.88M |
| 2 |
2
Axa
Paris,
France
|
$3.47M |
| 3 |
BFA
3
BlackRock Fund Advisors
San Francisco,
California
|
$2.86M |
| 4 |
4
Franklin Resources
San Mateo,
California
|
$9.42M |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$1.47M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
JPMorgan Chase & Co
New York
| – | – | -3,025 | Closed |
|
52
Citigroup
New York
| – | – | -1,838 | Closed |
|
|
BJ
53
BlackRock Japan
Tokyo,
Japan
| – | – | -1,731 | Closed |
|
|
TRCT
54
Tower Research Capital (TRC)
New York
| – | – | -1,019 | Closed |
|
55
Wells Fargo
San Francisco,
California
| – | – | -270 | Closed |
|
|
CSS
56
Cubist Systematic Strategies
Stamford,
Connecticut
| – | – | -216 | Closed |
|